Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

10.0%

7 terminated/withdrawn out of 70 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

34%

24 trials in Phase 3/4

Results Transparency

70%

39 of 56 completed trials have results

Key Signals

1 recruiting39 with results

Enrollment Performance

Analytics

N/A
29(46.0%)
Phase 3
12(19.0%)
Phase 4
12(19.0%)
Phase 2
7(11.1%)
Phase 1
2(3.2%)
Early Phase 1
1(1.6%)
63Total
N/A(29)
Phase 3(12)
Phase 4(12)
Phase 2(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (70)

Showing 20 of 70 trials
NCT07086248Not ApplicableActive Not Recruiting

A Study to Determine if RADIESSE® Dilute Treatment in Décolleté of Adult Women Affects Radiographic Imaging Assessments

Role: lead

NCT07537855Phase 2Not Yet Recruiting

Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction: A Randomized Crossover Pilot Study

Role: collaborator

NCT07122193Phase 3Recruiting

A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

Role: lead

NCT05163353Not ApplicableCompleted

Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles

Role: lead

NCT05067504Not ApplicableCompleted

Effectiveness and Safety of the Octave System for Lifting the Eyebrow and Improving the Appearance of the Face and Neck

Role: lead

NCT06826391Not ApplicableEnrolling By Invitation

Using Calcium Hydroxylapatite To Treat Gum Recession and Tooth Hypersensitivity

Role: collaborator

NCT06093815Not ApplicableCompleted

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Role: lead

NCT05784363Phase 1Completed

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

Role: lead

NCT04622254Phase 3Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines

Role: lead

NCT04594213Phase 3Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines

Role: lead

NCT04594239Not ApplicableCompleted

Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow

Role: lead

NCT04681352Not ApplicableCompleted

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

Role: lead

NCT03650387Not ApplicableCompleted

Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face

Role: lead

NCT02949921Not ApplicableCompleted

Radiological Evaluation of Radiesse Implantation in the Hands

Role: lead

NCT03583359Not ApplicableCompleted

Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline

Role: lead

NCT03777917Not ApplicableCompleted

A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow

Role: lead

NCT05885035Phase 1Completed

Effects of Calcium Hydroxylapatite on Cellulite Dimples in the Buttocks

Role: collaborator

NCT02088632Phase 2Terminated

Incobotulinum Toxin for the Treatment of Trigeminal Neuralgia

Role: collaborator

NCT05222607Terminated

Longitudinal Evaluation and Real-world Evidence of NT201

Role: lead

NCT04886232Not ApplicableCompleted

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

Role: lead